BioAscent will be attending the Royal Society of Chemistry ‘Synthesis in Drug Discovery and Development’ event in Windlesham on 27 March.
The three main themes of the symposium are:
- Innovative synthesis facilitating candidate discovery
- Novel bioisosteres and methodology applicable to drug discovery
- Overcoming challenges of scale-up and process scale chemistry
The event is aimed at chemists from industry and academia, including synthetic, medicinal and process chemists.
Steve Hastwell, Business Development Director at BioAscent, and Jonathan Gillespie will be in attendance.
For more information, click here.